ATC B01AF01 · Antithrombotic Agents
Rivaroxaban shortage
As of 31 Oct 2026, Rivaroxaban has a reported shortage in 5 of the 5 countries we track (Germany, Italy, Spain, Austria, Belgium), covering 23 products.
Countries5/5
Products23packs or presentations
Short since27 Dec 202422 months ago
Earliest return31 Oct 2026company estimate
No return date8products
Main reasonManufacturing problem
Timeline
GermanyItalySpainAustriaBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Xarelto 1 mg/ml Granulat zur Herstellung einer Suspension zum Einnehmen | Bayer Aktiengesellschaft | 15 Jun 2026 | 31 Oct 2026 | Other Sonstige |
| DE | Xarelto 1 mg/ml Granulat zur Herstellung einer Suspension zum Einnehmen | Bayer Aktiengesellschaft | 24 Sep 2026 | 30 Nov 2026 | Other Sonstige |
| IT | RIVAROXABAN ZENTIVA ITALIA | ZENTIVA ITALIA S.R.L. | 27 Dec 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | RIVAROXABAN DR. REDDY'S | DR. REDDY'S S.R.L. | 15 Jul 2026 | not given | Increased demand Elevata richiesta: forniture discontinue (carenza relativa solo al canale ospedaliero) |
| IT | RIVAROXABAN DR. REDDY'S | DR. REDDY'S S.R.L. | 15 Jul 2026 | not given | Increased demand Elevata richiesta: forniture discontinue (carenza relativa solo al canale ospedaliero) |
| IT | RIVAROXABAN OLPHA | OLPHA AS | 26 Jul 2026 | 9 Nov 2026 | Manufacturing problem Problemi produttivi |
| IT | XARELTO | BAYER AG | 1 Sep 2026 | 2 Nov 2026 | Increased demand Elevata richiesta/problemi produttivi |
| IT | XARELTO announced | BAYER AG | 2 Nov 2026 | 31 Dec 2026 | Increased demand Elevata richiesta |
| ES | XARELTO 1 mg/ml GRANULADO PARA SUSPENSION ORAL, 1 frasco de 2,625 g de granulado | Bayer Ag | 26 Oct 2026 | 28 Jan 2027 | Not stated |
| AT | Rivaroxaban 1A Pharma 2,5 mg - Filmtabletten, 60 Stück | 1 A Pharma GmbH | 16 Mar 2026 | not given | Increased demand Erhöhter Mehrbedarf |
| AT | Rivaroxaban +pharma 2,5 mg Filmtabletten, 100 Stück | +pharma Arzneimittel gmbh | 16 Jun 2026 | 14 Dec 2026 | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Rivaroxaban Genericon 2,5 mg Filmtabletten, 60 Stück | Genericon Pharma Ges.m.b.H. | 10 Aug 2026 | 7 Dec 2026 | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Xarelto 1 mg/ml Granulat zur Herstellung einer Suspension zum Einnehmen, 250 ml | Bayer AG | 19 Aug 2026 | 13 Nov 2026 | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
| AT | Rivaroxaban ratiopharm 20 mg Filmtabletten, 28 Stück | ratiopharm Arzneimittel Vertriebs GmbH | 24 Aug 2026 | not given | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Xarelto 15 mg Filmtabletten, 14 Stück | Bayer AG | 3 Sep 2026 | 8 Nov 2026 | Increased demand Erhöhter Mehrbedarf |
| AT | Rivaroxaban Genericon 2,5 mg Filmtabletten, 30 Stück | Genericon Pharma Ges.m.b.H. | 9 Sep 2026 | 7 Dec 2026 | Manufacturing problem Verzögerung bei der Herstellung |
| AT | Rivahib 2,5 mg-Filmtabletten, 60 Stück | G.L. Pharma GmbH | 10 Sep 2026 | 20 Nov 2026 | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
| AT | Rivaroxaban 1A Pharma 15 mg – Filmtabletten, 42 Stück | 1 A Pharma GmbH | 29 Sep 2026 | not given | Increased demand Erhöhter Mehrbedarf |
| AT | Rivaroxaban 1A Pharma 15 mg – Filmtabletten, 28 Stück | 1 A Pharma GmbH | 29 Oct 2026 | not given | Increased demand Erhöhter Mehrbedarf |
| BE | Rivaroxaban Sandoz 2.5 mg film-coat. tabl. 196 | Sandoz | 19 Nov 2025 | 28 Dec 2026 | Manufacturing problem Delay in production |
| BE | Rivaroxaban Sandoz 2.5 mg film-coat. tabl. 56 (56 x 1) UD | Sandoz | 10 Aug 2026 | 13 Nov 2026 | Manufacturing problem Delay in production |
| BE | Rivaroxaban Sandoz 15 mg film-coat. tabl. 42 (42 x 1) UD | Sandoz | 12 Aug 2026 | 13 Nov 2026 | Manufacturing problem Delay in production |
| BE | Xarelto 1 mg/ml or. susp. (gran.) 5.25 g | Bayer | 28 Sep 2026 | not given | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.